Effect of the p38 kinase inhibitor, SB 203580, on allergic airway inflammation in the rat

British Journal of Pharmacology

Volumn 131, Issue 2, 2000, Pages 173-176

  Escott, K J ^a   Belvisi, M G ^a   Birrell, M A ^a   Webber, S E ^a   Foster, M L ^a   Sargent, C A ^a  

^a Aventis Pharma Ltd   (United Kingdom)

Author keywords

Allergic airway inflammation; p38 kinase; Tumour necrosis factor

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ALLERGEN; ANTIGEN; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; OVALBUMIN; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTHMA; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; EOSINOPHILIA; FEMALE; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATORY CELL; LUNG LAVAGE; NEUTROPHILIA; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY TRACT INFLAMMATION;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; BRONCHIAL HYPERREACTIVITY; BRONCHIAL PROVOCATION TESTS; BRONCHOALVEOLAR LAVAGE; CELL MOVEMENT; DISEASE MODELS, ANIMAL; ENZYME INHIBITORS; FEMALE; HYPERSENSITIVITY; IMIDAZOLES; MITOGEN-ACTIVATED PROTEIN KINASES; OVALBUMIN; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PYRIDINES; RATS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0033778848     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0703605     Document Type: Article

References (18)

1. Specific inhibitors of p38 and extracellular signal-regulated kinase and mitogen-activated protein kinase pathways block inducible nitric oxide synthase and tumor necrosis factor accumulation in murine macrophages stimulated with lipopolysaccharide and interferon-gamma
2. Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxic shock and immune function
3. SB 203580 inhibits p38 mitogen-activated protein kinase, nitric oxide production and inducible nitric oxide synthase in bovine cartilage-derived chondrocytes
4. Effect of the p38 kinase inhibitor, SB 203580, in a model of airway inflammation
5. Cytokines in symptomatic asthma airways
6. Effect of SB 203580 on murine airway inflammation
7. Pharmacological effects of SB 220025, a selective inhibitor of p38 mitogen-activated protein kinase, in angiogenesis and chronic inflammatory disease models
8. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
9. Role of CSBP/p38/RK stress response kinase in LPS and cytokine signaling mechanisms
10. TNF-α mediates recruitment of neutrophils and eosinophils during airway inflammation
11. Proinflammatory cytokine-induced and chemical mediator-induced IL-8 expression in human bronchial epithelial cells through p38 mitogen-activated protein kinase-dependent pathway
12. Potential role of interleukin-1 in allergen-induced late asthmatic reactions in guinea pigs: Suppressive effect of interleukin-1 receptor antagonist on late asthmatic reaction
13. Pharmacological evidence for tumor necrosis factor as a mediator of allergic inflammation in the airways
14. Tumour necrosis factor alpha: A potential mediator of asthma
15. Tumor necrosis factor-alpha increases airway responsiveness and sputum neutrophilia in normal human subjects
16. RPR 106541, a novel, airways-selective glucocorticoid: Effects against antigen-induced CD4 + T lymphocyte accumulation and cytokine gene expression in the Brown Norway rat lung
17. Molecular cloning and characterization of a novel p38 mitogen-activated protein kinase
18. Cytokines contribute to airway dysfunction in antigen-challenged guinea pigs: Inhibition of airway hyperreactivity, pulmonary eosinophil accumulation and tumor necrosis factor generation by pretreatment with an interleukin-I receptor antagonist